Augusto Banayat
Nurse Practitioner · San Bernardino, CANPI 1831727700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,982 and has fallen 93.9% since, to $183 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Novartis$607
- Mallinckrodt Hospital Products Inc.$510
- Boehringer Ingelheim$485
- AbbVie$467
- Johnson & Johnson$420
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,98297%
- Education$1603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 53 | $1,384 |
| Novartis | 28 | $607 |
| Mallinckrodt Hospital Products Inc. | 24 | $510 |
| Boehringer Ingelheim | 18 | $485 |
| AbbVie | 24 | $467 |
| Johnson & Johnson | 20 | $420 |
| Pfizer | 16 | $363 |
| Aurinia Pharma U.S., Inc. | 13 | $355 |
| UCB, Inc. | 11 | $266 |
| Lilly USA, LLC | 10 | $233 |
| AstraZeneca(2 entities) | 10 | $208 |
| GSK | 8 | $163 |
| Actelion Pharmaceuticals US, Inc. | 5 | $157 |
| ANI Pharmaceuticals, Inc. | 5 | $90 |
| Bioventus LLC | 3 | $63 |
| CSL Behring | 2 | $58 |
| Lundbeck LLC | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $39 |
| Biocryst US Sales Co., LLC | 1 | $30 |
| Hospira, Inc. | 1 | $26 |
| Echosens North America, Inc. | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$235
- LUPKYNIS$125
- EVENITY$125
- SIMPONI ARIA$110
- TEPEZZA$106
How this compares
$6,142 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amjevita(Cf) AutoinjectorAdalimumab-Atto | 13 | $18,781 |
| Hydroxychloroquine Sulfate | 123 | $4,107 |
| MethotrexateMethotrexate Sodium | 73 | $1,936 |
| Mycophenolate Mofetil | 19 | $1,617 |
| Alendronate Sodium | 47 | $1,092 |
| Leflunomide | 23 | $1,060 |
| Prednisone | 65 | $741 |
| Leucovorin Calcium | 12 | $559 |
| Colchicine | 12 | $489 |
| Allopurinol | 28 | $208 |
| Gabapentin | 12 | $160 |
| Methylprednisolone | 16 | $135 |
| Folic Acid | 20 | $91 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in San Bernardino
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.